These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29517357)

  • 41. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mature Oocyte Cryopreservation for Fertility Preservation.
    Liang T; Motan T
    Adv Exp Med Biol; 2016; 951():155-161. PubMed ID: 27837562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oocyte cryopreservation: advances and drawbacks.
    Dovey S
    Minerva Ginecol; 2012 Dec; 64(6):485-500. PubMed ID: 23232533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Planned oocyte cryopreservation: the state of the ART.
    Cascante SD; Berkeley AS; Licciardi F; McCaffrey C; Grifo JA
    Reprod Biomed Online; 2023 Dec; 47(6):103367. PubMed ID: 37804606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disposition intentions of elective egg freezers toward their surplus frozen oocytes: a systematic review and meta-analysis.
    Caughey LE; Lensen S; White KM; Peate M
    Fertil Steril; 2021 Dec; 116(6):1601-1619. PubMed ID: 34452749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First successful delivery in Texas using vitrified human oocytes: a case report.
    Hickman TN; McKenzie LJ; Schlenker T; Pinasco MA
    J Reprod Med; 2013; 58(11-12):538-40. PubMed ID: 24568050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death.
    Inhorn MC; Birenbaum-Carmeli D; Patrizio P
    Soc Sci Med; 2017 Dec; 195():25-33. PubMed ID: 29121511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Social Freezing: Pressing Pause on Fertility.
    Varlas VN; Bors RG; Albu D; Penes ON; Nasui BA; Mehedintu C; Pop AL
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oocyte cryopreservation for social reasons: demographic profile and disposal intentions of UK users.
    Baldwin K; Culley L; Hudson N; Mitchell H; Lavery S
    Reprod Biomed Online; 2015 Aug; 31(2):239-45. PubMed ID: 26099440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cryopreserved oocytes: update on clinical applications and success rates.
    Paramanantham J; Talmor AJ; Osianlis T; Weston GC
    Obstet Gynecol Surv; 2015 Feb; 70(2):97-114. PubMed ID: 25671372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decision making processes of women who seek elective oocyte cryopreservation.
    Kim R; Yoon TK; Kang IS; Koong MK; Kim YS; Kim MJ; Lee Y; Kim J
    J Assist Reprod Genet; 2018 Sep; 35(9):1623-1630. PubMed ID: 30006788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical and social egg freezing: internet-based survey of knowledge and attitudes among women in Denmark and the UK.
    Lallemant C; Vassard D; Nyboe Andersen A; Schmidt L; Macklon N
    Acta Obstet Gynecol Scand; 2016 Dec; 95(12):1402-1410. PubMed ID: 27638056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postponing Childbearing and Fertility Preservation in Young Professional Women.
    Hurley EG; Ressler IB; Young S; Batcheller A; Thomas MA; DiPaola KB; Rios J
    South Med J; 2018 Apr; 111(4):187-191. PubMed ID: 29719026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethics of medical and nonmedical oocyte cryopreservation.
    Patrizio P; Molinari E; Caplan A
    Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):470-475. PubMed ID: 27653001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline.
    Dolmans MM; Donnez J
    Minerva Ginecol; 2018 Aug; 70(4):402-407. PubMed ID: 29644332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in fertility preservation.
    Dolmans MM; Manavella DD
    J Obstet Gynaecol Res; 2019 Feb; 45(2):266-279. PubMed ID: 30246274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
    Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
    Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.